USPTO serial 87679942
NEOANTIGEN DISCOVERY
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- BELLO, ZACK
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NEOANTIGEN DISCOVERY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jennifer L. Whitelaw
JENNIFER L. WHITELAW WHITELAW LEGAL GROUP3838 TAMIAMI TRAIL NORTH, SUITE 310NAPLES, FL 34103UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Pre-packaged medical tests kits and medical test kits to aid in the diagnosis of disease or cancer, namely, kits primarily composed of DNA probes and also containing clinical medical reagents and antibodies for use in disease testing for clinical medical laboratory use | ACTIVE | — |
| 005 | Medical tests kits primarily comprised of medical diagnostic reagents and assays for testing body fluids | ACTIVE | — |
| 009 | Downloadable webinars in the fields of pathology, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions; downloadable electronic publications in the nature of newsletters and abstracts in the fields of pathology, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions; software for medical testing and analysis of medical test results; software for enhanced analyzing, researching, and reviewing of medical, scientific, and genetic information, testing and analysis; computer software to acquire, capture, extract, except, analyze, organize, and manage medical testing, biological information, medical tests, medical test data, and medical test results for the processing of test data and for analysis of medical test results; computer software for enhancing the analysis of research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information and pertaining to testing and analysis | ACTIVE | — |
| 042 | Medical and scientific research information in the field of human disease and human medical conditions; scientific testing and research services in the field of human disease and human medical conditions; providing medical research services in the field of human disease and human medical conditions; providing clinical scientific testing services and medical research and testing in the field of human disease and human medical conditions; clinical laboratory services, oncology reference laboratory services; providing information, interactive information, and reports to others in the field of medical tests, medical testing, medical research, pathology, diagnostic testing, oncology testing and human disease and medical conditions; providing information to others in the field of scientific testing and research and clinical scientific testing; providing an internet website portal featuring information in the field of scientific testing and research, medical research, and clinical scientific testing; providing cloud-based information to others in the field of scientific testing and research, medical research, and clinical scientific testing; providing online non-downloadable Internet-based software for medical testing and analysis of medical test results; providing online non-downloadable Internet-based software for enhanced analyzing, researching, and reviewing of medical, scientific, and genetic information, testing and analysis; software as a service (SAAS) services featuring software for medical testing and analysis of medical test results; Software as a service (SAAS) services featuring software for enhanced analyzing, researching, and reviewing of medical, scientific, and genetic information, testing and analysis; genetic mapping for scientific purposes, namely, gene sequencing, molecular sequencing, cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells; medical and scientific research information in the field of gene sequencing, molecular sequencing, cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells; scientific research in the field of gene sequencing, molecular sequencing, cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells, and cancer | ACTIVE | — |
| 044 | Medical information; medical diagnostic testing services in the field of human disease and human medical conditions; medical diagnostic testing, monitoring and reporting services; genetic testing for medical purposes; medical testing for diagnostic or treatment purposes; providing medical information to others in the field of human disease, human medical conditions, medical diagnostic testing, and medical testing for diagnostic or treatment purposes; providing an Internet website portal featuring medical information in the field of human disease, human medical conditions, medical diagnostic testing, medical testing for diagnostic or treatment purposes, and the delivery of scientific and medical test results; providing cloud-based medical information to others in the field of human disease, human medical conditions, medical diagnostic testing, and medical testing for diagnostic or treatment purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by NeoGenomics Laboratories, Inc.
- Other trademarks owned by NeoGenomics Laboratories, Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named NEOANTIGEN DISCOVERY
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 13, 2020 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 13, 2020 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 13, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 12, 2019 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Sep 11, 2019 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Sep 9, 2019 | EXT3 | SOU EXTENSION 3 FILED | — |
| Sep 9, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 3, 2019 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Mar 6, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 4, 2019 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Mar 4, 2019 | EXT2 | SOU EXTENSION 2 FILED | — |
| Mar 4, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 7, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 5, 2018 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Sep 5, 2018 | EXT1 | SOU EXTENSION 1 FILED | — |
| Sep 5, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 13, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 16, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 16, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 27, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 6, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 29, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 21, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 14, 2017 | NWAP | NEW APPLICATION ENTERED | — |